|
Newspaper Discovers Many Dialysis Patients Not Told of Kidney ... - InjuryBoard.com (blog) |
|
|
InjuryBoard.com (blog)The Pittsburgh Tribune-Review recently conducted a four-month review of records from the US Renal Data System and discovered that some dialysis patients ... |
|
AEterna Zentaris Partner, Keryx, Presented Updated Phase 2 Data on ... - Genetic Engineering News (press release) |
|
|
Genetic Engineering News (press release)Dr. Hutson's presentation, entitled "Phase 2 study of perifosine in patients with metastatic renal cell carcinoma progressing after prior therapy with both ...Updated Single Agent Phase 2 Data of KRX-0401 (Perifosine) in the ... Earthtimes (press release)Keryx Biopharma Announces Updated Clinical Results From Phase 2 ... RTT NewsKeryx Biopharmaceuticals, Inc. to Raise $20 Million in Registered ... |
Dynavax Resumes Hepatitis B Vaccine Trial After 18-Month Hold - Update - RTT News |
|
|
RTT NewsAccording to statistics, there are about 750000 end-stage renal disease, or ESRD, patients in the United States and the 5 major European markets and ...Dynavax Initiates Phase 3 Registration Trial in Chronic Kidney ... |
|
Kidney failure 'on the rise' - The Australian |
|
|
The AustralianArticle from: Australian AP THE number of people experiencing kidney failure and requiring dialysis is escalating at an alarming rate, according to new ... |
Merck Receives Positive CHMP Opinion For JANUVIA (Sitagliptin) - Pharmaceutical Online (press release) |
|
|
Pharmaceutical Online (press release)Because JANUVIA is renally eliminated, and to achieve plasma concentrations of JANUVIA similar to those in patients with normal renal function, ...New Analysis of Pooled Clinical Data Shows 'Januvia®' (sitagliptin ... |
|
|
|
<< Start < Prev 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 Next > End >>
|
Page 1999 of 2630 |